191 related articles for article (PubMed ID: 35992269)
21. ZEB1 Promotes Chemoresistance to Cisplatin in Ovarian Cancer Cells by Suppressing SLC3A2.
Cui Y; Qin L; Tian D; Wang T; Fan L; Zhang P; Wang Z
Chemotherapy; 2018; 63(5):262-271. PubMed ID: 30481785
[TBL] [Abstract][Full Text] [Related]
22. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
Xu Z; Chen X; Song L; Yuan F; Yan Y
Front Immunol; 2022; 13():834595. PubMed ID: 35281049
[TBL] [Abstract][Full Text] [Related]
23. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
[TBL] [Abstract][Full Text] [Related]
24. IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer.
Zhang L; Liu W; Liu F; Wang Q; Song M; Yu Q; Tang K; Teng T; Wu D; Wang X; Han W; Li Y
Oxid Med Cell Longev; 2020; 2020():1675613. PubMed ID: 32322334
[TBL] [Abstract][Full Text] [Related]
25. xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.
Liu J; Xia X; Huang P
Mol Ther; 2020 Nov; 28(11):2358-2366. PubMed ID: 32931751
[TBL] [Abstract][Full Text] [Related]
26. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
[TBL] [Abstract][Full Text] [Related]
27. The role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance of pancreatic cancer.
Tang R; Hua J; Xu J; Liang C; Meng Q; Liu J; Zhang B; Yu X; Shi S
Ann Transl Med; 2020 Nov; 8(21):1347. PubMed ID: 33313092
[TBL] [Abstract][Full Text] [Related]
28. GPX4 Plays a Crucial Role in Fuzheng Kang'ai Decoction-Induced Non-Small Cell Lung Cancer Cell Ferroptosis.
Zhao YY; Yang YQ; Sheng HH; Tang Q; Han L; Wang SM; Wu WY
Front Pharmacol; 2022; 13():851680. PubMed ID: 35496303
[No Abstract] [Full Text] [Related]
29. The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.
El Ansari R; Craze ML; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Br J Cancer; 2018 Apr; 118(8):1115-1122. PubMed ID: 29545595
[TBL] [Abstract][Full Text] [Related]
30. Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression.
Hu Z; Yin Y; Jiang J; Yan C; Wang Y; Wang D; Li L
J Gastrointest Oncol; 2022 Apr; 13(2):754-767. PubMed ID: 35557596
[TBL] [Abstract][Full Text] [Related]
31. xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers.
Lee N; Carlisle AE; Peppers A; Park SJ; Doshi MB; Spears ME; Kim D
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672555
[TBL] [Abstract][Full Text] [Related]
32. SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma.
Cheng X; Wang Y; Liu L; Lv C; Liu C; Xu J
Front Mol Biosci; 2022; 9():889688. PubMed ID: 35517862
[No Abstract] [Full Text] [Related]
33. The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.
El-Ansari R; Craze ML; Alfarsi L; Soria D; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 May; 175(1):27-38. PubMed ID: 30671766
[TBL] [Abstract][Full Text] [Related]
34. Can CD147 work as a therapeutic target for tumors through COVID-19 infection?
Ren HL; Wen GM; Zhao ZY; Liu DH; Xia P
Int J Med Sci; 2022; 19(14):2087-2092. PubMed ID: 36483594
[TBL] [Abstract][Full Text] [Related]
35. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.
Huang Y; Dai Z; Barbacioru C; Sadée W
Cancer Res; 2005 Aug; 65(16):7446-54. PubMed ID: 16103098
[TBL] [Abstract][Full Text] [Related]
36. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Wang S; Chen S; Ying Y; Ma X; Shen H; Li J; Wang X; Lin Y; Liu B; Zheng X; Xie L
Front Cell Dev Biol; 2021; 9():676142. PubMed ID: 34291048
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Two Ferroptosis Subtypes With Distinct Immune Infiltration and Gender Difference in Gastric Cancer.
Ma J; Hu X; Yao Y; Wu L; Sheng C; Chen K; Liu B
Front Nutr; 2021; 8():756193. PubMed ID: 34977116
[No Abstract] [Full Text] [Related]
39. A Systematic Review of the Tumor-Infiltrating CD8
Shadbad MA; Asadzadeh Z; Hosseinkhani N; Derakhshani A; Alizadeh N; Brunetti O; Silvestris N; Baradaran B
Front Immunol; 2021; 12():734956. PubMed ID: 34603316
[TBL] [Abstract][Full Text] [Related]
40. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
